TELIF (Telescope Innovations) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


TELIF Telescope Innovations Corp TELIF
31 GF Score
Price $0.58
GF Value $0.40
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Telescope Innovations Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Telescope Innovations's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

TELIF vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Telescope Innovations's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telescope Innovations Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's Margin of Safety % (DCF Earnings Based) falls into.


TELIF
31GF Score
Telescope Innovations Corp TELIF
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.58 is trading 44% above its estimated GF Value™ of $0.40. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $0.40 vs. price of $0.58 (44% above fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
31GF Score

Get the complete analysis for TELIF

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$0.40
GF Value